Publications by authors named "Siyrous Hoseyni Guyomi"
Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Youlan L Gu Marthe A Kampinga Wouter G Wieringa Marieke L Fokkema Maarten W Nijsten Siyrous Hoseyni Guyomi
Circulation
December 2010
Article Synopsis
- The study evaluated the effectiveness of intracoronary versus intravenous administration of the glycoprotein IIb/IIIa inhibitor abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
- Results showed no significant difference in the incidence of complete ST-segment resolution between the two methods, but intracoronary administration led to better myocardial blush grades and reduced enzymatic infarct size.
- The rate of major adverse cardiac events was similar for both administration routes, indicating that while intracoronary abciximab may enhance certain aspects of myocardial healing, it does not significantly improve overall myocardial reperfusion.
Article Synopsis
- A 41-year-old woman successfully received a Figulla atrial septum occluder device with no immediate complications.
- Five months later, the device dislocated and was found in the abdominal aorta, near the celiac axis, posing a risk of obstruction.
- The device was removed through a medial rotation approach due to its total incorporation in the aorta, highlighting a rare complication in atrial septum defect procedures and prompting discussion on retrieval methods.
Objectives: To evaluate outcomes after percutaneous coronary intervention (PCI) with a drug-eluting balloon catheter (paclitaxel-coated) in patients with coronary artery bifurcation lesions.
Background: The current practice of provisional stenting of the main branch (MB) is reasonable; however, long-term results of side-branch (SB) treatment are suboptimal. The use of drug-eluting stents has not improved these results, regardless of the implantation technique, and could potentially lead to a significant increase in (late) thrombotic events.